Detalhe da pesquisa
1.
The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer.
J Urol
; 209(6): 1120-1131, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789668
2.
Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?
Future Oncol
; 19(31): 2075-2082, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646326
3.
The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups.
Prostate
; 82(13): 1237-1247, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675470
4.
Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?
Future Oncol
; 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226872
5.
An empirical investigation of time-varying cost-effectiveness across the product life cycle.
Health Econ
; 29(5): 580-590, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083778
6.
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 20(4): 556-569, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770294
7.
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
N Engl J Med
; 375(23): 2246-2254, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718781
8.
Safety and effectiveness of classical and alternative sunitinib dosing schedules for metastatic renal cell carcinoma: a meta-analysis.
Future Oncol
; 15(18): 2175-2190, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010323
9.
Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses.
BMC Cancer
; 18(1): 1271, 2018 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30567533
10.
Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell Carcinoma.
Value Health
; 21(12): 1413-1418, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30502785
11.
Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma.
J Oncol Pharm Pract
; 24(8): 574-583, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732453
12.
Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538879
13.
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer.
Prostate Cancer Prostatic Dis
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565911
14.
R-SIM: A Database of Binding Affinities for RNA-small Molecule Interactions.
J Mol Biol
; 435(14): 167914, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495921
15.
Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting.
Prostate Cancer Prostatic Dis
; 26(3): 523-530, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517634
16.
Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 21(4): 419-429, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36842915
17.
Nonfatal myocardial infarction and long-term outcomes in coronary artery disease.
Am Heart J
; 163(1): 95-103, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22172442
18.
Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 25(3): 524-530, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732856
19.
Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials.
Prostate Cancer Prostatic Dis
; 25(2): 288-295, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518652
20.
Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats.
J Physiol
; 589(Pt 5): 1195-208, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21224224